Cargando…
Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines
SIMPLE SUMMARY: Neuroblastoma is the most common extra-cranial tumor in children and despite medical advancements in cancer treatment, five-year survival for high-risk neuroblastoma remains less than 50%. Investigation of the mechanisms responsible for aggressive disease is necessary to identify nov...
Autores principales: | Bownes, Laura V, Williams, Adele P, Marayati, Raoud, Quinn, Colin H, Hutchins, Sara C, Stewart, Jerry E, Vu, Trung, Easlick, Juliet L, Mroczek-Musulman, Elizabeth, Crossman, David K, Anderson, Joshua C, Willey, Christopher D, Datta, Pran K, Beierle, Elizabeth A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268080/ https://www.ncbi.nlm.nih.gov/pubmed/34206917 http://dx.doi.org/10.3390/cancers13133201 |
Ejemplares similares
-
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells
por: Marayati, Raoud, et al.
Publicado: (2022) -
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
por: Bownes, Laura V., et al.
Publicado: (2022) -
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
por: Bownes, Laura V., et al.
Publicado: (2021) -
Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor
por: Quinn, Colin H., et al.
Publicado: (2021) -
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
por: Quinn, Colin H., et al.
Publicado: (2022)